Literature DB >> 10993926

The effects of antiviral therapy on the distribution of herpes simplex virus type 1 to ganglionic neurons and its consequences during, immediately following and several months after treatment.

Alana M Thackray1, Hugh J Field1.   

Abstract

Both famciclovir (FCV) and valaciclovir (VACV) are potent inhibitors of herpes simplex virus type 1 (HSV-1) in a murine cutaneous infection model. The object of the present study was to determine whether either drug had an effect on the anatomical distribution of infected neurons in the peripheral nervous system and to assess the consequences for infected cells during, immediately following and several months after a 9 day period of continuous treatment. Mice were inoculated via the neck with a recombinant strain of HSV-1 expressing the lacZ reporter gene under the immediate-early gene promoter. Sensory ganglia were sampled daily up to day 11 post-inoculation (p.i.) and infected cells were detected by means of the reporter gene product. Ganglia were also removed at 1.5 and 10 months p.i. and latency was assessed by explant co-cultivation and by using in situ hybridization to detect LAT-expressing neurons. While both drugs reduced the severity of acute infection markedly, neither compound completely prevented the relentless distribution of infection among peripheral nervous tissue. Furthermore, there was a difference between the compounds regarding the expression of the reporter gene during and after termination of treatment and in the number of residual LAT-positive neurons.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10993926     DOI: 10.1099/0022-1317-81-10-2385

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  5 in total

1.  Analysis of herpes simplex virus ICP0 promoter function in sensory neurons during acute infection, establishment of latency, and reactivation in vivo.

Authors:  R L Thompson; May T Shieh; N M Sawtell
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

2.  Noninvasive bioluminescence imaging of herpes simplex virus type 1 infection and therapy in living mice.

Authors:  Gary D Luker; J Patrick Bardill; Julie L Prior; Christina M Pica; David Piwnica-Worms; David A Leib
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

3.  Tracking the spread of a lacZ-tagged herpes simplex virus type 1 between the eye and the nervous system of the mouse: comparison of primary and recurrent infection.

Authors:  C Shimeld; S Efstathiou; T Hill
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

4.  PrP(c) expression influences the establishment of herpes simplex virus type 1 latency.

Authors:  Alana M Thackray; Raymond Bujdoso
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

5.  Herpes simplex virus type 1 latently infected neurons differentially express latency-associated and ICP0 transcripts.

Authors:  Séverine Maillet; Thierry Naas; Sophie Crepin; Anne-Marie Roque-Afonso; Florence Lafay; Stacey Efstathiou; Marc Labetoulle
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.